Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population
Clinical trial NCT01015443 · TERMINATED
Trial details
- NCT number
- NCT01015443
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2015-06-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.